Pessimistic
发表于 2025-3-21 17:07:18
书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0463216<br><br> <br><br>书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0463216<br><br> <br><br>
预定
发表于 2025-3-21 23:34:52
,The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982–2003,ber of global, first-in-class, biotech and orphan drugs exhibited more positive trends. U.S. headquartered firms also assumed a strong leadership position in terms of being the initial introducers of the most novel compounds including first-in-class, biotech and orphan drugs.
澄清
发表于 2025-3-22 01:58:57
When patents are not enough: Supplementary incentives for pharmaceutical innovation, where for some reason the value of the patent reward is relatively low compared to the social value created by the innovation: that is, where the . of social value is low. In these cases, firms will fail to invest in innovation even though its value to society is high.
召集
发表于 2025-3-22 08:10:41
http://reply.papertrans.cn/47/4633/463216/463216_4.png
拱形大桥
发表于 2025-3-22 12:26:05
http://reply.papertrans.cn/47/4633/463216/463216_5.png
jet-lag
发表于 2025-3-22 14:17:59
http://reply.papertrans.cn/47/4633/463216/463216_6.png
除草剂
发表于 2025-3-22 17:48:48
http://reply.papertrans.cn/47/4633/463216/463216_7.png
灿烂
发表于 2025-3-22 23:03:28
Textbook 2011 size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
CLOT
发表于 2025-3-23 01:43:44
http://reply.papertrans.cn/47/4633/463216/463216_9.png
自爱
发表于 2025-3-23 06:49:20
Aidan Hollisut program into a sequence of steps in a machine program, and they then describe the interfaces between the modules. Finally, the structures of real translators are outlined. The book contains the necessary theory and advice for implementation.. .This book is intended for students of computer scienc